YARTEMLEA
NDC 62225-300, narsoplimab, injection, from Omeros Corporation.
- Product NDC
- 62225-300
- Status
- Listed
- Labeler
- Omeros Corporation
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761152
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62225-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NARSOPLIMAB370 mg/2mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62225-300-00 | 62225030000 | 1 VIAL in 1 CARTON (62225-300-00) / 2 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f8ff990a-0d2e-433f-9615-b9b097448991Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=62225-300
Use it
Look up 62225-300 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62225-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62225-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.